Top Biotechnology companies in Hong Kong by Price to Book Ratio (P/B)

This ranking features the top 7 Biotechnology companies in Hong Kong ranked by Price to Book Ratio (P/B), averaging a Price to Book Ratio (P/B) of 2.10, for January 15, 2025.
#
Name
Price to Book Ratio (P/B)
Reported Date
Stock Price
Change
Price (30 days) Country
1

6.20

Jan. 14, 2025 USD 14.74 7.67%

Hong Kong

2

3.18

Jan. 14, 2025 USD 3.02 2.59%

Hong Kong

3

1.56

Jan. 14, 2025 USD 0.37 1.03%

Hong Kong

4

1.18

Jan. 14, 2025 USD 0.21 8.82%

Hong Kong

5

1.02

Jan. 14, 2025 USD 0.39 0.30%

Hong Kong

6

0.82

Jan. 14, 2025 USD 0.26 2.03%

Hong Kong

7

0.77

Jan. 14, 2025 USD 0.83 3.07%

Hong Kong

Frequently Asked Questions
  • Which Biotechnology company in Hong Kong has the highest Price to Book Ratio (P/B) ?

    The Biotechnology company in Hong Kong with the highest Price to Book Ratio (P/B) is BeiGene, Ltd. (HKSE: 6160.HK) at 6.20.

  • Which Biotechnology company in Hong Kong has the lowest Price to Book Ratio (P/B) ?

    The Biotechnology company in Hong Kong with the lowest Price to Book Ratio (P/B) is Guangdong Hybribio Biotech Co.,Ltd. (Shenzhen Stock Exchange: 300639.SZ) at 0.77.